{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:15:38Z","timestamp":1769598938644,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.cld.2008.09.013","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T09:26:41Z","timestamp":1232011601000},"page":"117-126","source":"Crossref","is-referenced-by-count":66,"title":["Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis"],"prefix":"10.1016","volume":"13","author":[{"given":"Quentin M.","family":"Anstee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Thursz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"issue":"9055","key":"10.1016\/j.cld.2008.09.013_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/gut.52.4.574","article-title":"Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2008.09.013_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.510270535","article-title":"Determinants of outcome of compensated hepatitis C virus-related cirrhosis","volume":"27","author":"Serfaty","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.510290424","article-title":"The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States","volume":"29","author":"Hu","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2008.09.013_bib7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/hep.510280632","article-title":"Prognosis of chronic hepatitis C: results of a large, prospective cohort study","volume":"28","author":"Niederau","year":"1998","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2008.09.013_bib8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c","volume":"34","author":"Poynard","year":"2001","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2008.09.013_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.1840050422","article-title":"Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3","volume":"5","author":"MacPhee","year":"1985","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0026-2862(88)90014-3","article-title":"Microcirculatory changes in livers of mice infected with murine hepatitis virus: evidence from microcorrosion casts and measurements of red cell velocity","volume":"36","author":"MacPhee","year":"1988","journal-title":"Microvasc Res"},{"issue":"6","key":"10.1016\/j.cld.2008.09.013_bib12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.1840030614","article-title":"The effect of mouse hepatitis virus infection on the microcirculation of the liver","volume":"3","author":"Levy","year":"1983","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2008.09.013_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI18114","article-title":"The Fgl2\/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis","volume":"112","author":"Marsden","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0016-5085(95)90211-2","article-title":"Accumulation and cellular localization of fibrinogen\/fibrin during short-term and long-term rat liver injury","volume":"108","author":"Neubauer","year":"1995","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2008.09.013_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","article-title":"Coagulation status modulates hepatic fibrosis: implications for the development of novel therapies","volume":"6","author":"Anstee","year":"2008","journal-title":"Journal of Thrombosis & Haemostasis"},{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0037-1615623","article-title":"Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury","volume":"85","author":"Xu","year":"2001","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.cld.2008.09.013_bib17","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2008.09.013_bib18","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/gut.52.3.404","article-title":"Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis","volume":"52","author":"Papatheodoridis","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","author":"Poujol-Robert","year":"2004","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1572-0241.2004.04092.x","article-title":"Genetic and acquired thrombotic factors in chronic hepatitis C","volume":"99","author":"Poujol-Robert","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2893.2006.00790.x","article-title":"The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source","volume":"14","author":"Goulding","year":"2007","journal-title":"J Viral Hepat"},{"issue":"6","key":"10.1016\/j.cld.2008.09.013_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.47.6.845","article-title":"The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985","volume":"47","author":"Yee","year":"2000","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules","volume":"27","author":"Tanaka","year":"1998","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2008.09.013_bib25","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/jhep.2000.20350","article-title":"Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection","volume":"32","author":"Nakazawa","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib26","first-page":"579A","article-title":"Secondary parenchymal damages in cirrhotic livers associated with activated platelet aggregation in sinusoids","volume":"46","author":"Ikura","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.cld.2008.09.013_bib27","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1111\/j.1440-1746.2004.03705.x","article-title":"Pathogenesis of cirrhosis","volume":"19","author":"Wanless","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2008.09.013_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/hep.510240417","article-title":"Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole","volume":"24","author":"Wanless","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2008.09.013_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2004-823104","article-title":"The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis","volume":"24","author":"Wanless","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"3 Suppl","key":"10.1016\/j.cld.2008.09.013_bib30","first-page":"11S","article-title":"Thrombin interactions","volume":"124","author":"Di","year":"2003","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 antagonism protects against experimental liver fibrosis: role of proteinase receptors in stellate cell activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.510270221","article-title":"Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury","volume":"27","author":"Marra","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0168-8278(01)00285-9","article-title":"Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors","volume":"36","author":"Gaca","year":"2002","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2008.09.013_bib34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62354-1","article-title":"Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis","volume":"166","author":"Howell","year":"2005","journal-title":"Am J Pathol"},{"issue":"6801","key":"10.1016\/j.cld.2008.09.013_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2008.09.013_bib36","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis: from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2008.09.013_bib37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI27183","article-title":"Ligation of protease-activated receptor 1 enhances alphavbeta6 integrin-dependent TGF-beta activation and promotes acute lung injury","volume":"116","author":"Jenkins","year":"2006","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.cld.2008.09.013_bib38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1440-1746.2007.05220.x","article-title":"Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis","volume":"23","author":"Martinelli","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2008.09.013_bib39","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/gut.2003.032136","article-title":"A role for thrombin in liver fibrosis","volume":"53","author":"Duplantier","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2008.09.013_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.phrs.2004.04.009","article-title":"A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat","volume":"51","author":"Abdel-Salam","year":"2005","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.cld.2008.09.013_bib41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","author":"Abe","year":"2007","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2008.09.013_bib42","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.2201082","article-title":"Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits","volume":"168","author":"Gunther","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.cld.2008.09.013_bib43","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3748\/wjg.v9.i7.1611","article-title":"Effects of heparin on liver fibrosis in patients with chronic hepatitis B","volume":"9","author":"Shi","year":"2003","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2008.09.013_bib44","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1378\/chest.128.3.1475","article-title":"Anticoagulant therapy for idiopathic pulmonary fibrosis","volume":"128","author":"Kubo","year":"2005","journal-title":"Chest"},{"issue":"9591","key":"10.1016\/j.cld.2008.09.013_bib45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial","volume":"370","author":"Eriksson","year":"2007","journal-title":"Lancet"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T06:09:09Z","timestamp":1531634949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1089326108000962"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.09.013","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}